Your browser doesn't support javascript.
loading
Chance of reimbursement for ADD-ON therapies in Poland and in the world - review of the reimbursement recommendations
Borowiack, Ewa; Marzec, Magdalena; Nowotarska, Anna; Jarosz, Joanna; Orkisz, Agata; Przada-Machno, Patrycja.
Affiliation
  • Borowiack E; NUEVO HTA CLP
  • Marzec M; NUEVO HTA CLP
  • Nowotarska A; NUEVO HTA CLP
  • Jarosz J; NUEVO HTA CLP
  • Orkisz A; NUEVO HTA CLP
  • Przada-Machno P; Pfizer LLC
Przegl Epidemiol ; 72(1): 99-109, 2018.
Article in En | MEDLINE | ID: mdl-29667385
Subject(s)
Key words
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement Mechanisms / Breast Neoplasms / Urogenital Neoplasms / Antineoplastic Agents, Immunological / Antibodies, Monoclonal Type of study: Guideline / Health_technology_assessment / Prognostic_studies Limits: Female / Humans Language: En Journal: Przegl Epidemiol Year: 2018 Document type: Article
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement Mechanisms / Breast Neoplasms / Urogenital Neoplasms / Antineoplastic Agents, Immunological / Antibodies, Monoclonal Type of study: Guideline / Health_technology_assessment / Prognostic_studies Limits: Female / Humans Language: En Journal: Przegl Epidemiol Year: 2018 Document type: Article